Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Subcutaneous, every-four-week maintenance dosing of a novel protein S antibody is well-tolerated and substantially reduces bleeding rates: Results from A phase 1/2 multidose study of VGA039 in patients with von Willebrand disease

Allison Wheeler, Shrinath Kshirsagar, Adam Giermasz, Johnny Mahlangu, Gabriela Yamaguti-Hayakawa, Savita Rangarajan, Genevieve Moyer, Christine Kempton, Almudena Tercero, Paul Sims, Sandip Panicker, Chris Foo, Eileen Sawyer, Chris Del Nagro, Gary Patou, Benjamin Kim, Nicoletta Machin

Blood (2025) 146 (Supplement 1): 308.

https://doi.org/10.1182/blood-2025-308

Published: 2025

Journal Articles

Factor VIII Coagulant Activity (FVIII:C) As an Independent Predictor of Bleeding across Different Subtypes of Von Willebrand Disease (VWD)

Shruti Vilas Kharat, Nayaab Khan, Alina He, Chris Foo, Kranti Patil, Gurpreetkaur Saini, Shreyas Tawde, Benjamin Kim, Savita Rangarajan, Shrimati Shetty

Blood (2024) 144 (Supplement 1): 3982.

https://doi.org/10.1182/blood-2024-209566

Published: 2024